Oligo Business Growth

Integrated DNA Technologies (IDT) has purchased the oligo business of VH Bio Ltd IDT will supply VH Bio’s customers from IDT’s state-of-theart facility in Leuven, Belgium, while building on the excellent local customer service for which VH Bio has been renowned in the UK. As a result, current VH Bio oligo customers will have access to a much broader range of products, with 100% QC-checked sequences and next-day delivery. VH Bio will continue to distribute its full range of other products for immunologists and molecular biologists.

IDT and VH Bio have also announced an agreement to work together to grow IDT’s oligonucleotide business in the UK. The two companies will combine efforts to introduce IDT’s market-leading products to scientists throughout the country.

Dr Joseph A. Walder, IDT’s founder and CEO, commented: “From its earliest beginnings, IDT’s mission has been to provide scientists with the very best in synthetic oligonucleotides. IDT has always understood that to mean peerless quality, leading technology, the broadest scope, and truly collaborative customer service – all at the lowest cost possible to the researcher. We are eager to serve VH Bio’s customers and are honored that VH Bio has chosen to entrust their customers to us.”

Andrew Hewitt, VH Bio’s Managing Director, remarked: “IDT has clearly established itself as the market leader in oligonucleotide synthesis, innovation, and service. We’re looking forward to sharing with our colleagues here in the UK what we’ve come to know about IDT’s unmatched ability to support researchers in both academia and industry. This agreement will also facilitate the continuing expansion of the molecular biology product lines we presently offer.”

IDT officially opened its European synthesis facility in Leuven in September 2008, and now has branches in both the UK and Germany.